Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele De Marco

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Rheumatology (Oxford, England)|June 17, 2026
Whole body-MRI identifies widespread, low intensity inflammation in peripheral joints, and axial involvement in a third of patients with early, treatment-naïve, active psoriatic arthritis: Data from the GOLMePsA clinical trialGabriele De Marco, Walter P Maksymowych, Mikkel Østergaard, et al.
RMD Open|April 5, 2024
High prevalence of radiographic erosions in early, untreated PsA: results from the SpARRO cohortOr Hen, Andrea Di Matteo, Sayam R Dubash, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2025
Late-Onset Spondylarthritis Presenting as Glucocorticoid-Resistant Polymyalgia Rheumatica: A hitherto underappreciated entity where TNF or IL-17 Blockade may have a Therapeutic RoleKerem Abacar, Gabriele De Marco, Jake Weddell, et al.
Rheumatology Advances in Practice|March 14, 2022
Ultrasound shows swollen joints are the better proxy for synovitis than tender joints in DMARD-naïve early psoriatic arthritisSayam R Dubash, Oras A Alabas, Xabier Michelena, et al.
The Lancet. Rheumatology|September 6, 2025
Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trialGabriele De Marco, Elizabeth M A Hensor, Philip S Helliwell, et al.
Joint Bone Spine|May 27, 2026
Two Patterns of Sacroiliac Joint Bone Marrow Oedema are apparent in AxSpA Determined by HLA-B27 Status, Body Mass Index or PsoriasisKerem Abacar, Andrea Di Matteo, Gabriele De Marco, et al.
RMD Open|August 14, 2025
Using ultrasound to define inflammatory and non-inflammatory phenotypes in difficult-to-treat psoriatic arthritisAlen Zabotti, Nicola Cabas, Cristina Di Nicola, et al.
Clinical and Experimental Rheumatology|October 31, 2024
A new instrument for the screening of psoriatic arthritis among psoriatic patientsGabriele De Marco, Antonio Marchesoni, Maria Manara, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
GRAPPA 2019 Project ReportNiti Goel, Laura C Coates, Gabriele De Marco, et al.
Rheumatology Advances in Practice|February 5, 2021
Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiativeGabriele De Marco, Anna Berekméri, Laura C Coates, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|June 17, 2026
Whole body-MRI identifies widespread, low intensity inflammation in peripheral joints, and axial involvement in a third of patients with early, treatment-naïve, active psoriatic arthritis: Data from the GOLMePsA clinical trialGabriele De Marco, Walter P Maksymowych, Mikkel Østergaard, et al.
RMD Open|April 5, 2024
High prevalence of radiographic erosions in early, untreated PsA: results from the SpARRO cohortOr Hen, Andrea Di Matteo, Sayam R Dubash, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2025
Late-Onset Spondylarthritis Presenting as Glucocorticoid-Resistant Polymyalgia Rheumatica: A hitherto underappreciated entity where TNF or IL-17 Blockade may have a Therapeutic RoleKerem Abacar, Gabriele De Marco, Jake Weddell, et al.
Rheumatology Advances in Practice|March 14, 2022
Ultrasound shows swollen joints are the better proxy for synovitis than tender joints in DMARD-naïve early psoriatic arthritisSayam R Dubash, Oras A Alabas, Xabier Michelena, et al.
The Lancet. Rheumatology|September 6, 2025
Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trialGabriele De Marco, Elizabeth M A Hensor, Philip S Helliwell, et al.
Joint Bone Spine|May 27, 2026
Two Patterns of Sacroiliac Joint Bone Marrow Oedema are apparent in AxSpA Determined by HLA-B27 Status, Body Mass Index or PsoriasisKerem Abacar, Andrea Di Matteo, Gabriele De Marco, et al.
RMD Open|August 14, 2025
Using ultrasound to define inflammatory and non-inflammatory phenotypes in difficult-to-treat psoriatic arthritisAlen Zabotti, Nicola Cabas, Cristina Di Nicola, et al.
Clinical and Experimental Rheumatology|October 31, 2024
A new instrument for the screening of psoriatic arthritis among psoriatic patientsGabriele De Marco, Antonio Marchesoni, Maria Manara, et al.
The Journal of Rheumatology. Supplement|June 3, 2020
GRAPPA 2019 Project ReportNiti Goel, Laura C Coates, Gabriele De Marco, et al.
Rheumatology Advances in Practice|February 5, 2021
Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiativeGabriele De Marco, Anna Berekméri, Laura C Coates, et al.
Pageof 5